{"title":"RVL Pharmaceuticals","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cspan data-copy-service-computed-style='font-family: \"Google Sans\", Arial, sans-serif; font-size: 16px; font-weight: 600; margin: 0px; text-decoration: none; border-bottom: 0px rgb(230, 232, 240);' data-subtree=\"aimfl,mfl\"\u003eRVL Pharmaceuticals\u003c\/span\u003e is \u003c!--qkimaf pBaOp_h\/HugV6--\u003e\u003c!--cqw1tb pBaOp_h\/HugV6--\u003ea specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products for underserved patient populations\u003c!--TgQPHd|[]--\u003e.\u003c\/p\u003e","products":[{"product_id":"upneeq®-oxymetazoline-hcl-ophthalmic-solution-0-1","title":"Upneeq® (Oxymetazoline HCl Ophthalmic Solution 0.1%)","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eUpneeq (oxymetazoline hydrochloride ophthalmic solution, 0.1%) is the first and only FDA-approved prescription treatment for acquired blepharoptosis — clinically drooping upper eyelids in adults.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eHow It Works\u003c\/strong\u003e Upneeq targets Müller's muscle in the upper eyelid via alpha-adrenergic agonist action, causing controlled muscle contraction that lifts the eyelid. Results are visible within 5–15 minutes and last up to 6–8 hours.\u003c\/p\u003e","brand":"RVL Pharmaceuticals","offers":[{"title":"Default Title","offer_id":51873848197406,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0864\/6977\/1550\/files\/hero-section-img-CeQKr2Ip.webp?v=1779287458"}],"url":"https:\/\/6d06d0-a7.myshopify.com\/collections\/rvl-pharmaceuticals.oembed","provider":"The Luxe Room","version":"1.0","type":"link"}